Multiple Sulfatase Deficiency Disease
Merck Moves All R&D Operations Out of UK, Citing Unfavorable Environment
Merck; MSD; R&D relocation; UK life sciences; drug discovery; Brexit impact; London Bioscience Innovation Centre; Francis Crick Institute; government investment; layoffs